Conference Description:

The diagnostic field is booming with global interest as companies race to be the first to develop diagnostics and vaccines for the novel coronavirus. More than ever before we are seeing diagnostic, pharmaceutical and academic expertise coming together to deliver in record-breaking speed. As attention starts to shift back to existing pipeline candidates, what lessons can we learn to deliver personalized therapies in a more time effective manner?

Uniting biomarker, translational, clinical, diagnostic and commercial thought leaders, the Digital Clinical Biomarkers and World CDx meeting will address key questions raised following the rapid COVID-19 response and delivers exciting case studies from pioneering teams in personalized therapeutics. Helping you expedite end-to-end drug development; this is not a conversation to miss.

With three days dedicated to help you overcome your most pressing challenges, ensure you are here for conversations with pharma on the COVID response, the rise of T-cell based therapeutics in personalized medicine and exciting case studies spanning early studies to delivering commercial strategies.

There will also be a pre-conference workshop day, focusing on Women and Diversity in Precision Medicine - creating diverse and inclusive working environments recognizing and championing the achievements of all.

The digital Women and Diversity in Precision Medicine event will unite all leaders of the scientific and business community, from pharma, lab, academic and Dx backgrounds to foster collaboration, advocate mentorship and derive actionable solutions to help improve inclusion across the industry.

Through illuminating presentations, dynamic panels, interactive working sessions and focused networking, this event will sharpen your leadership skills, facilitate meaningful connections and equip you with the tools and insight to inspire long lasting beneficial changes for your career and business.

https://worldcdx-digital.com/
Main Conference - 29 September - 01 October, 2020
8.00am - 5.20pm EST | 5.00am - 2.20pm PST

https://worldcdx-digital.com/women-div ersity-precision-medicine/
Pre-Conference Mastermind Day 28 September
9.30am-6.30pm EST | 6.30am-3.30pm PST

Contact:
[email protected]

URLs:
Tickets: https://go.evvnt.com/663897-1?pid=154
Website: https://go.evvnt.com/663897-4?pid=154
Twitter: https://go.evvnt.com/663897-5?pid=154

Time: 08:00 to 17:20

Price:
General Admission: USD 0.00

Speakers: Jennifer Hamilton, Executive Director and Head, Precision Medicine, Regeneron, Sid Mathur, Regulatory Affairs Director, Companion Diagnostics, Merck and Co., Julie Ramage, Director, Precision Medicine Quality Initiatives and Partnerships, AstraZeneca, Jeffrey Emch, Vice President, Global Companion Diagnostics Strategy, Oncology, GSK, Jennifer Herring, Executive Director and Head, Cellular Therapy Clinical Research Scientists, Bristol Myers Squibb, Lourdes Barrera, Senior Director, Precision Medicine, Global Precision Medicine Strategy, Oncology Business Unit, Novartis